Health Care: Drugs

Halozyme Therapeutics Inc (HALO: NASDAQ)

$16.86 -0.085 | -0.5%
04/24/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 16.95
52 Week High 17.00
52 Week Low 6.88
Avg. Daily Vol. (Mil) 1.42
Beta (3 year) 0.84
Share Related Items
Mkt Cap (Mil) 2,152.29
Shares Out (Mil) 126.70
Float (Mil) 105.86
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.00
Current Ratio 6.60
LT Debt/ Equity 1.21
Total Debt / Equity 1.21
Valuation Ratios
Price Earnings n.a.
Price/Sales 28.50
Price/Book 51.92
Price/Cash Flow -33.00
Per Share Data
Earnings -0.56
Sales 0.59
Book Value 0.33
Cash Flow -0.51
Business Summary
Halozyme Therapeutics Inc is a biopharmaceutical company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.
General Information
11388 Sorrento Valley Road
San Diego, CA 92121
www.halozyme.com
Industry : Drugs
Sector: Health Care
Employees: 153
CEO: Dr. Helen Torley, MB.Ch.
Short Interest
Current Month (Mil) 16.46
Previous Month (Mil) 18.06
Short Interest Ratio (Days) 9.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -41.20
Return on Investments -75.00
Profitability
Gross Margin 74.10
EBIT Margin -83.40
Profit Margin -90.80

Portfolios with HALO

Latest HALO Headlines from TheStreet

More Financial News for HALO

Press Releases for HALO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter